Anzeige
Mehr »
Login
Samstag, 05.12.2020 Börsentäglich über 12.000 News von 647 internationalen Medien
Unfassbare News! Grande West: Erster Kunde unterzeichnet Kaufvertrag für Vicinity Lighting E-Busse!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14SSK ISIN: US5288723027 Ticker-Symbol: LX31 
Frankfurt
04.12.20
16:09 Uhr
1,286 Euro
-0,001
-0,04 %
1-Jahres-Chart
LEXICON PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
LEXICON PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,2841,33104.12.
1,2771,33704.12.

Aktuelle News zur LEXICON PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.11.BCLI Flunks Phase II ALS Study, LXRX Aces Sotagliflozin Trials, KZIA On Watch, FDA Snubs Alkermes875LONDON (dpa-AFX) - Today's Daily Dose brings you news about FDA's refusal to approve Alkermes' antipsychotic drug ALKS 3831, BrainStorm's NurOwn failing in amyotrophic lateral sclerosis study...
► Artikel lesen
17.11.Lexicon Pharmaceuticals News: Why LXRX Stock Is Soaring 43% Today12
17.11.Why Lexicon Pharmaceuticals Stock Is Trading Higher Today7
LEXICON PHARMACEUTICALS Aktie jetzt für 0€ handeln
17.11.Lexicon Pharmaceuticals, Zomedica Pharmaceuticals leads healthcare gainers; Brainstorm Cell Therapeutics, GoodRx Holdings among losers20
17.11.Lexicon Pharma +45% after drug shows benefits for heart patients21
17.11.LEXICON PHARMACEUTICALS, INC. - 8-K, Current Report8
17.11.Lexicon Pharmaceuticals, Inc.: Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association ...20
02.11.Lexicon Has Cleaned Up Its Balance Sheet To Take Another Run At A Meaningful Commercial Product9
29.10.Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q3 2020 Results - Earnings Call Transcript6
29.10.Lexicon Pharmaceuticals: Q3 Earnings Insights5
29.10.LEXICON PHARMACEUTICALS, INC. - 8-K, Current Report-
29.10.Lexicon Pharmaceuticals, Inc.: Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical Update3
22.10.LEXICON PHARMACEUTICALS, INC. - 8-K, Current Report3
29.09.LEXICON PHARMACEUTICALS, INC. - 8-K, Current Report3
24.09.The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO28
24.09.LEXICON PHARMACEUTICALS, INC. - 8-K, Current Report2
24.09.Lexicon Pharmaceuticals launches exchange offer for convertible 2021 notes5
24.09.Lexicon Pharmaceuticals, Inc.: Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness2
09.09.IN BRIEF: BioPharma Credit Secures USD124.5 Million Lexicon Repayment4
09.09.BioPharma Credit PLC: LEXICON PHARMACEUTICALS PREPAYMENT4
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1